Finance entity
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention Argus Research, the most common co-covered peer. The 6 average consequence score is below the beat benchmark of 6.3 in the same window.
Last mentioned: 5h ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention Argus Research, the most common co-covered peer. The 6 average consequence score is below the beat benchmark of 6.3 in the same window. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. We currently track 1 Finance story that mention KEYTRUDA, all published on August 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering KEYTRUDA. Shared-story counts are live from our verified record — not editorial picks.
Argus raised Merck's price target to $145 on pipeline depth and M&A, while Merck disclosed a small strategic stake in Evaxion. For investors, the story is the huge gap between a mega-cap's $16.6 billion quarter and a micro-cap's cash-burning AI bet.
KEYTRUDA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
